The Challenge of Keeping Up: SARS-CoV-2 Mutations vs. Vaccine Development

While we now have the capability to map a virus in just 48 hours, the real challenge lies in scaling up production and rapidly distributing the vaccine. Moreover, there are individuals spreading fear and misinformation, discouraging others from getting vaccinated.

Understanding Vaccines and Variants

Vaccines are designed to catch up with significant mutations that already exist. However, the premise of the question itself reveals a misunderstanding of the current situation. Put simply, many people have been infected with variants of the virus without even noticing, due to the high similarity of the virus to other, existing strains.

The Lack of Need for Vaccines

The reason why there have been no attempts to create a vaccine specifically against SARS-CoV-2 is straightforward. Research indicates that a significant portion of the human population carries a similar virus, COV-NL63, without any signs of immunity. This makes it unlikely that a vaccine could effectively target such pathogens.

Misinformation and Vaccine Efficacy

Claims that the mRNA serum is creating variants and a manufactured plandemic are baseless. The virus mutates rapidly, much like gossip, making it challenging to develop new vaccines before the next variant arises. Furthermore, experiments have shown that current vaccines were not effective in preventing infection, illness, or transmission.

Alternative Approaches

Fortunately, there are several safe and effective treatments available that can provide quick relief. For the vast majority of the population, having sufficient vitamin C, D, and zinc in their diet will be sufficient to ensure a mild or asymptomatic infection. Natural immunity following such an infection will provide genuine protection, unlike the false promise of vaccines.

The Process of Adapting Vaccines

Even if a vaccine were to be modified to match a mutated virus, the process is lengthy and cumbersome. First, a copy of the mutated virus needs to be obtained. Then, the vaccine must be modified, which can take from 2 to multiple months. Post-modification, the vaccine must be extensively tested, a process that also takes months. Lastly, production and distribution would need to occur. This lengthy process means that mutations often outpace vaccine development.

In conclusion, while the virus continues to mutate rapidly, the current vaccine development process is not yet up to the task of adapting to every new variant. It's essential to prioritize accurate information and alternative methods of protecting public health.